Hormone receptor expression and clinicopathologic features in male and female breast cancer

7Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Background: Male and female breast cancers were investigated for variation in the clinicopathologic characteristics and expression of steroid hormone receptors in the northeast of Iran. Materials and Methods: Tumor specimens of 17 males and 338 females with breast cancer were collected at the hospitals of Mashhad University of Medical Sciences. Immunohistochemical expression of hormone receptors and clinicopathologic features of breast cancer were compared between two groups. Results: The mean age in men was 15 years higher than women (p=0.000). Males and females were mainly in stage II and III respectively (p=0.007). Although more than 60% of male and female patients were grade II, the respective figures for grade I and III were 25% and 12.5% in men but 7.1% and 27.2% in women respectively (p=0.025). ER was significantly more positive in men against women; 82.3% versus 53.4% (p=0.016). The related measures for PR was 58.8% and 50.3%, respectively (p=0.424). Males also showed significantly more ER expression than postmenopausal females; 82.3% versus 48.9% (p=0.010). Conclusions: Breast cancer in males and females contrasted in age at diagnosis, histological type, stage, grade and ER expression which emphasize they are separate diseases with different behaviors.

Cite

CITATION STYLE

APA

Shandiz, F. H., Tavassoli, A., Sharifi, N., Khales, S. A., Kadkhodayan, S., & Khales, S. A. (2015). Hormone receptor expression and clinicopathologic features in male and female breast cancer. Asian Pacific Journal of Cancer Prevention, 16(2), 471–474. https://doi.org/10.7314/APJCP.2015.16.2.471

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free